MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Development"

  • 2025 International Congress

    Expanding the Clinical Spectrum of Fejerman Syndrome: Insights from Video EEG and Long-Term Follow-Up

    M. Hull, M. Sudheendra, M. Gonzalez, B. Evans, D. Takacs, A. Katyayan (Houston, USA)

    Objective: We review the clinical spectrum of infants diagnosed with Fejerman syndrome, provide detailed phenomenology through video review and long-term outcomes Background: First described by…
  • 2025 International Congress

    Clinical and Genetic spectrum of Developmental dyskinetic encephalopathy – Experience from a Tertiary care centre

    A. Vijayaraghavan, S. Nair, S. Sundaram (Thiruvananthapuram, India)

    Objective: To provide unique data on the clinical and genetic spectrum of developmental dyskinetic encephalopathies. Background: Developmental dyskinetic encephalopathy(DDE) is a recently described clinically and…
  • 2025 International Congress

    Precision Gene Therapy Results in Clinical Benefit and Developmental Gains for Aromatic L-Amino Acid Decarboxylase Deficiency (AADCd): The UK Experience

    A. Salazar-Villacorta, R. Spaull, L. Carr, J. Hassell, S. Pope, S. Heales, R. Shihurkar, K. Bankiewicz, T. Pearson, K. Aquilina, M. Kurian (London, United Kingdom)

    Objective: To describe the UK cohort of children who have received regional brain-targeted gene therapy (GT) for AADCd Background: Classical AADCd is an ultra-rare genetic…
  • 2025 International Congress

    Using Zebrafish Model to Investigate Complex Hereditary Spastic Paraplegia Caused by EPT1 Variants

    S. Wang, S. Banka, M. Lowe, A. Nicolaou (Manchester, United Kingdom)

    Objective: To generate disease-representative zebrafish models using CRISPR-Cas9 technique.To characterise the zebrafish models by performing phenotypic characterization, neurobiological experiments, lipidomic and RNASeq studies.To test targeted…
  • 2025 International Congress

    Development and Testing of a Smartphone Application to Capture Patient-Centered Outcome (PCO) Measures for Dystonia

    P. Reyes, A. Tingin, B. Berman, S. Schneider, J. Hieshetter, K. Kuman, G. Kilic-Berkmen, L. Wright, F. Qeadan, J. Perlmutter, H. Jinnah, S. Pirio-Richardson (Richmond, USA)

    Objective: Develop a smartphone application to collect patient-centered outcome (PCO) measures for dystonia. Background: PCO measures tailored for each major adult-onset focal dystonia subtype (Cervical…
  • 2025 International Congress

    Caregiver and Patient perspectives on Parkinson’s Disease at tertiary, urban teaching hospital in Zambia, Africa: A Focus Group Study

    J. Purks, G. Habanyama, L. Chishimba (Rochester, USA)

    Objective: Conduct focus groups to better understand the lived experience of Parkinson's Disease (PD) patients and caregivers in Zambia. Background: PD is a global neurological disease with…
  • 2025 International Congress

    Monitoring Parkinson’s Disease in the Dental Chair

    J. Schwartz, L. Dibenedetto, P. Engen, V. Ha, B. Killinger, C. Soto, S. Green, A. Naqvi, S. Tomar, M. Shaikh, M. Villanueva, D. Sanchez-Bass, C. Noh, R. Voigt, C. Goetz, A. Keshavarzian (Chicago, USA)

    Objective: Our goal is to bridge the mechanistic knowledge gap on the Microbiota-Gut-Oral-Brain-Axis (MGOBA)’s role in Parkinson’s disease (PD) pathogenesis through a case-control, proof-of-concept, observational…
  • 2025 International Congress

    Privacy and Personalisation: Predicting Parkinson’s Severity with Federated Learning

    C. Hinchliffe, H. Hiden, E. Packer, P. Brown, A. Yarnell, L. Rochester, L. Alcock, M. Peeters, S. Del Din, P. Watson (Newcastle upon Tyne, United Kingdom)

    Objective: To improve privacy and personalisation for artificial intelligence (AI), this work compared federated learning (FL) to a conventional, centralised system for predicting Movement Disorder…
  • 2025 International Congress

    The Impact of Socioeconomic Status on Functionality in people with Parkinson’s Disease

    A. Paixão, N. Pereira, R. Luz, E. Oliveira, I. Chaves, G. Vanucci, M. Piemonte (São Paulo, Brazil)

    Objective: To investigate the impact of socioeconomic status (SES) on functionality in people with Parkinson's disease (PD) using the World Health Organization Disability Assessment Schedule…
  • 2025 International Congress

    A Novel Quantitative Assessment to Evaluate Functional Impairment in Parkinson’s Disease

    V. Vanchinathan, M. Farah, A. Singh, C. Zhang, N. Osei-Owusu, R. Desai, R. Palani, J. Hamkins, M. Zwernemann, S. Grill, A. Pantelyat, J. Brašić (Baltimore, USA)

    Objective: To investigate if motion data collected from inertial measurement units (IMUs) mounted on implements used in activities of daily living (ADLs) can characterize the…
  • 1
  • 2
  • 3
  • …
  • 9
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • #28953 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley